Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report

Respiratory Medicine

Volumn 101, Issue 7, 2007, Pages 1419-1425

  Pietinalho, A ^a   Kinnula, V L ^b   Sovijarvi A R A ^b   Vilkman, S ^c   Saynajakangas O ^d   Liippo, K ^e   Kontula, E ^a   Laitinen, L A ^b  

^a Finnish Lung Health Association   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Porvoo Hospital   (Finland)

^d LAPLAND CENTRAL HOSPITAL   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chronic bronchitis; COPD; Guidelines; Obstructive pulmonary disease; Smoking cessation; Treatment programme

Indexed keywords

TOBACCO SMOKE;

ADULT; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST BENEFIT ANALYSIS; DEATH; DEVICE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FINLAND; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; PENSIONER; PREVALENCE; PRIORITY JOURNAL; REHABILITATION CARE; SMOKING HABIT; SPIROMETRY;

BRONCHITIS, CHRONIC; DELIVERY OF HEALTH CARE, INTEGRATED; EARLY DIAGNOSIS; FEMALE; FINLAND; HOSPITALIZATION; HUMANS; MALE; PREVALENCE; PROGRAM EVALUATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY; TOBACCO SMOKE POLLUTION;

EID: 34249795476     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.01.022     Document Type: Article

References (35)

1. Aromaa A, Heliövaara M, Impivaara O. Terveys, toimintakyky ja hoidontarve Suomessa. Kansaneläkelaitoksen julkaisuja, vol. AL: 32. Helsinki ja Turku, 1989 [in Finnish].
2. Krooninen keuhkoputkitulehdus ja keuhkoahtaumatauti. Valtakunnallinen ehkäisy- ja hoitoohjelma 1998-2007. Sosiaali- ja terveysministeriö. Julkaisuja 1998; 4 [in Finnish].
3. Chronic bronchitis and chronic obstructive pulmonary disease. National Guidelines for prevention and treatment 1998-2007. Ministry of Social Affairs and Health. Publications, 1998:16.
4. Laitinen L, Koskela K and the expert advisory group listed in the foreword. Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998-2007. Respir Med 1999;93:297-332.
5. The Finnish Respiratory Society. COPD treatment guideline. Duodecim 1999;115:496-505 [in Finnish].
6. Working Group appointed by the Finnish Association for General Practice. Smoking, nicotine dependency and smoking cessation. Evidence Based Medicine guideline. Duodecim 2002. 〈http://www.kaypahoito.fi/〉 [in English].
7. Sovijärvi ARA, Piirilä P, Korhonen O, Louhiluoto E, Pekkanen L, Forstedt M. Performance and evaluation of spirometric and PEF measurements, offprint 3. KP-paino, Kokkola: Kliinisten Laboratoriotutkimusten Laaduntarkkailu Oy; Moodi 1995 [in Finnish].
8. Heloma A., Jaakkola M.S., Kähkönen E., and Reijula K. The short-term impact of national smoke-free workplace legislation on passive smoking and tobacco use. Am J Public Health 91 9 (2001) 1416-1418
9. Helakorpi S, Patja K, Prättälä R, Aro AR, Uutela A. The health behavior of Finnish adults. The National Health Institute B17/2003, spring 2003. 〈www.ktl.fi.〉 [in Finnish].
10. Jaakkola N., Jaakkola M.S., Gissler M., and Jaakkola J.J.K. Smoking during pregnancy in Finland: determinants and trends, 1987-1997. Am J Public Health 91 (2001) 284-286
11. Kotaniemi J.T., Sovijärvi A., and Lundbäck B. Chronic obstructive pulmonary disease in Finland: prevalence and risk factors. COPD: J Chronic Obstructive Pulm Dis 3 (2005) 331-339
12. Säynäjäkangas O, Lampela P, Pietinalho A, Kontula E, Tuuponen T, Keistinen T. Keuhkoahtaumataudin valtakunnallinen ehkäisy- ja hoito-ohjelma puolivälissä-miten sairaalahoidon tarve on muuttunut? Finnish Med J 2003;58:4729-32 [in Finnish].
13. Ministry of Social Affairs and Health. Asthma Programme in Finland 1994-2004, with introduction by T. Haahtela, L.A. Laitinen. Report of a Working Group. Clin Exp Allergy 1996; 26 (Suppl.1): 1-24.
14. Erhola M., Mäkinen R., Koskela K., et al. The asthma programme of Finland: an evaluation survey in primary health care. Int J Tuberc Lung Dis 7 6 (2003) 592-598
15. Viljanen AA, editor. Reference values for spirometric, pulmonary diffusing capacity and body plethysmographic studies. Scand J Clin Invest 1982;42 (Suppl. 159):1-50.
16. Piirilä P., Pietinalho A., Loponen M., Naumanen H., Nurminen M., Salo S.-P., et al. The quality of spirometric examinations in Finland; results from a national questionnaire survey. Clin Physiol Funct Imaging 22 (2002) 233-239
17. Vilkman S., Nyberg A., Poussa T., and Ranta P. Keuhkoahtaumataudin (COPD) akuutin pahenemisvaiheen hoito kotisairaalassa. Finnish Med J 56 43 (2001) 4387-4391 [In Finnish]
18. Act on health care devices and equipment. Finnish Law So 511.29.12.1994/1505.
19. Hämäläinen P. Home respiratory care. PhD Thesis, monography, Acta Universitatis Tamperensis 673, University of Tampere, 1999.
20. Hassi J., Remes J., Kotaniemi J.-T., Kettunen P., and Näyhä S. Dependence of cold-related coronary and respiratory symptoms on age and exposure to cold. Int J Circumpolar Health 59 (2000) 210-215
21. Kotaniemi J.-T., Hassi J., Kataja M., et al. Does non-responder bias have a significant effect on the results in a postal questonaire study?. Eur J Epidemiol 17 (2002) 809-817
22. Kotaniemi J.-T., Pallasaho P., Sovijärvi A.R.A., Laitinen L.A., and Lundbäck B. Respiratory symptoms and asthma in relation to cold climate, inhaled allergens and irritants: a comparison between Northern and Southern Finland. J Asthma 39 7 (2002) 649-658
23. Lindström M., Kotaniemi J.-T., Jönsson E., and Lundbäck B. Smoking, respiratory symptoms and disease. Chest 119 (2003) 853-861
24. Kotaniemi J.-T., Latvala J., Lundbäck B., Sovijärvi A.R.A., Hassi J., and Larsson K. Does living in a cold climate or recreational skiing increase the risk for obstructive respiratory diseases or symptoms?. Int J Circumpolar Health 62 (2003) 142-157
25. Metso T., Rytilä P., Peterson C., and Haahtela T. Granulocyte markers in induced sputum in patients with respiratory diseases and healthy persons obtained by two sputum processing methods. Respir Med 1 (2001) 48-55
26. Rytilä P., Lindqvist A., and Laitinen L.A. Safety of sputum induction in chronic obstructive pulmonary disease of various degrees of severity. Eur Respir J 15 (2000) 1116-1119
27. Peleman R.A., Rytilä P.H., Kips J.C., Joos G.F., and Pauwels R.A. Cellular characteristics of induced sputum in COPD. Eur Respir J 13 (1999) 839-843
28. Harju T., Kaarteenaho-Wiik R., Soini Y., Sormunen R., and Kinnula V.L. Diminished immunoreactivity of γ-glutamylcysteine synthetase in the airways of smoker's lung. Am J Respir Crit Care Med 166 (2002) 754-759
29. Kinnula V.L., and Crapo J.D. Superoxide dismutase in lung and lung diseases. Review. Am J Respir Crit Care Med 167 (2003) 1600-1619
30. Kinnula V.L. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 60 (2005) 693-700
31. Jaakkola M.S., Piipari R., Jaakkola N., and Jaakkola J.J.K. Environmental tobacco smoke and adult-onset asthma: a population-based incident case-control study. Am J Public Health 93 12 (2003) 2055-2060
32. Lundbäck B., Lindberg A., Lindström M., et al. Not 15 but 50% of smokers develop COPD?-report from the obstructive lung disease in Northern Sweden Studies. Respir Med 97 (2003) 115-122
33. Keistinen T., Tuuponen T., Vilkman V., and Kivelä S.-L. Kun suuret ikäluokat sairastuvat. Kroonista ahtauttavaa keuhkosairautta sairastavien potilaiden sairaalapalvelujen tarpeesta 2000-luvun alkupuolella. Finnish Med J 51 (1996) 2395-2399 [in Finnish]
34. Lacasse Y., Ferreira I., Brooks D., Newman T., and Goldstein R.S. Critical appraisal of clinical guide lines targeting chronic obstructive pulmonary disease. Arch Acta Intern Med 16 1 (2001) 69-74
35. The Finnish Respiratory Society. Updated current care guideline for COPD. Duodecim 2003;119:2523-4.